Once-Weekly KRd Shows Promise in Newly Diagnosed MM
AJMC,
Corresponding author Melissa Alsina, MD, of Moffit Cancer Center in Florida, and colleagues wanted to know whether the therapy…
A phase 1b study of once‐weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
Overview of attention for article published in American Journal of Hematology, December 2020
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (84th percentile)
-
Good Attention Score compared to outputs of the same age and source (74th percentile)
Readers on
- mendeley
- 22 Mendeley